SCHEMBL23580948

SCHEMBL23580948

CC(C)=CCOc1cc(Br)cc(OC(F)(F)F)c1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MTNR1A P48039 1/20 0.36
TP53 P04637 1/20 0.34
MDM2 Q00987 1/20 0.34
GAA P10253 2/20 0.33
MAOB P27338 2/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
AOC3 Q16853 1/20 0.33
PTPN1 P18031 1/20 0.33
MGAM O43451 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
PPARG P37231 1/20 0.33
PGR P06401 1/20 0.32
TSHR P16473 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30279739 1.00 KDM4E (0.36) KDM4EALDH1A1MTNR1ATP53MDM2
SCHEMBL23580928 0.82 NOTUM (0.41) KDM4EALDH1A1MTNR1ATP53MDM2
SCHEMBL30279744 0.82 NOTUM (0.41) KDM4EALDH1A1MTNR1ATP53MDM2
SCHEMBL30279727 0.81 TP53 (0.47) KDM4EALDH1A1MTNR1ATP53MDM2
SCHEMBL30279813 0.81 KDM4E (0.39) KDM4EALDH1A1MTNR1ATP53MDM2
SCHEMBL23581049 0.81 TP53 (0.47) KDM4EALDH1A1MTNR1ATP53MDM2
SCHEMBL23580859 0.81 KDM4E (0.39) KDM4EALDH1A1MTNR1ATP53MDM2
SCHEMBL30349245 0.80 KDM4E (0.43) KDM4EALDH1A1MTNR1AGAAMAOB
SCHEMBL23580919 0.78 KDM4E (0.38) KDM4EALDH1A1MTNR1ATP53MDM2
SCHEMBL30279795 0.78 KDM4E (0.38) KDM4EALDH1A1MTNR1ATP53MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159421-A1 SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF Kynan Duke IP, LLC (US) 2023-05-25 US disclosed
US-20230159421-A1 SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF Kynan Duke IP, LLC (US) 2023-05-25 US disclosed
CN-115485259-A Substituted hydroxystilbene compounds and derivatives, synthesis and use thereof 凯楠公爵IP有限责任公司 2022-12-16 CN disclosed
WO-2021127743-A1 SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF Kynan Duke IP, LLC (US) 2021-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159421-A1 SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF CYP8B1, HSD11B1, HSD11B2 KDM4E 3324/4885ALDH1A1 288/4885MTNR1A 1856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.